首页> Pharmaceuticals (Basel, Switzerland)> Efficacy Analysis and Prognostic Impact of Sivelestat Sodium in Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome.

Efficacy Analysis and Prognostic Impact of Sivelestat Sodium in Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome.

导出 OA

翻译打印收藏纠错

第一作者： Xiao,Che

第一单位： Senior Department of Infectious Disease, The Fifth Medical Center of PLA General Hospital, Beijing 100039, China.

作者： Xiao,Che ^[1] ; Wei,Hu ^[1] ; Ziying,Zhang ^[1] ; Lexiao,Wang ^[1] ; Zhe,Xu ^[1] ; Fusheng,Wang ^[1]

作者单位： Senior Department of Infectious Disease, The Fifth Medical Center of PLA General Hospital, Beijing 100039, China. ^[1]

关键词 ARDS COVID-19 mortality rate sivelestat sodium

DOI 10.3390/ph17030368

PMID 38543154

发布时间 2024-04-26

基金项目

2020YFC0860900, 2022YFC2304803, 2022YFC2304404/Fu-sheng Wang, Zhe Xu

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Pharmaceuticals (Basel, Switzerland)

2024年17卷3期

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Efficacy Analysis and Prognostic Impact of Sivelestat Sodium in Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome.

Pharmaceuticals (Basel, Switzerland)

相似文献

同项目论文

Pharmaceuticals (Basel, Switzerland)

相关期刊

检索历史 清除

Efficacy Analysis and Prognostic Impact of Sivelestat Sodium in Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome.

Pharmaceuticals (Basel, Switzerland)

相似文献

同项目论文

Pharmaceuticals (Basel, Switzerland)

相关期刊

检索历史清除